Skip to content

Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia

Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03173339
Enrollment
92
Registered
2017-06-01
Start date
2017-06-01
Completion date
2017-08-24
Last updated
2017-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthroplasty

Keywords

intubation, pharyngitis, remifentanil

Brief summary

This investigation is planned to compare the incidence and severity of postoperative sore throat according to the dose of remifentanil.

Interventions

PROCEDUREEndotracheal intubation using laryngoscope

Endotracheal intubation was done using laryngoscope for general anesthesia.

DRUGHigh remifentanil

Remifentanil was started as 0.25 mcg/kg/min. Remifentanil dose was adjusted to maintain blood pressure (20% of preoperative blood pressure) and bispectral index (40-60) by 0.05 mcg/kg/min.

Remifentanil was administered as 0.1 mcg/kg/min.

DRUGHigh sevoflurane

Sevoflurane was started as 0.5 MAC. Sevoflurane dose was adjusted to maintain blood pressure (20% of preoperative blood pressure) and bispectral index (40-60) by 0.2 %.

DRUGLow sevoflurane

Sevoflurane was administered as 0.5 MAC.

Sponsors

Keimyung University Dongsan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-III * Patients scheduled for general anesthesia with endotracheal intubation

Exclusion criteria

* Difficult airway * Rapid sequence induction * Recent sore throat * Recent upper respiratory infection * Asthma * Chronic obstructive pulmonary disease * Chronic cough * Pregnancy * Allergy to remifentanil * Friable teeth * History of head and neck surgery * Multiple intubation attempts * Regional anesthetic agents * Gastric tube * Dexamethasone

Design outcomes

Primary

MeasureTime frame
Number of participants with sore throatAt 24 hr

Secondary

MeasureTime frame
Number of participants with hoarsenessAt 0, 2, 4 and 24 hr
Number of participants with coughAt 0, 2, 4 and 24 hr
Number of participants with nauseaAt 0, 2, 4 and 24 hr
Number of participants with vomitingAt 0, 2, 4 and 24 hr
Number of participants with sore throatAt 0, 2, 4 and 24 hr
Visual analogue scale of postoperative painAt 0, 2, 4 and 24 hr
Number of participants with shiveringAt 0, 2, 4 and 24 hr
Requirements of analgesicsAt 0, 2, 4 and 24 hr
Number of participants with additional pain medicationAt 0, 2, 4 and 24 hr

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026